OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

By D. Dodick, C. Turkel, R. Degryse, S. Aurora, S. Silberstein, Richard B. Lipton, H. Diener, M. Brin. Headache, 2010

892 citations recorded by the source corpus.

Subfields: Neurology, Psychiatry and Mental health, Surgery

View Paper: https://www.semanticscholar.org/paper/2941410f4e99f9ed80f36a52b8302dc07089fc33

Citations in the corpus

• Fremanezumab for the Preventive Treatment of Chronic Migraine (2017, neutral): “of patients (%) 141 (38) 153 (41) 67 (18)”